Digg It - Business

It has been well documented that employees' productivity and job quality increase when we are made to feel welcome at work. In

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

other words, when the motivational climate is enhanced to meet their needs they produce quality work at the 100% rate.

The s

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ource that caused them to produce at such high standards came from their employer's attempts at enhancing the motivational cl

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

imate. As a result, they came to work, not because they had to, but because they wanted to.

By listening to your employees, t

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ey will tell you what you need to do to enhance their motivational climate. In the meanwhile, here is a checklist to help you

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

get started. Ask yourself, Do I:

* encourage my employees to participate in goal-setting, planning, and decision-makin

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

g activities? ( ) Yes ( ) No

* give them credit and recognition when due? ( ) Yes ( ) No

* help them see the

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

Big Picture?( ) Yes ( ) No

* help them see what's in it for them? ( ) Yes ( ) No

* attend to their needs? (

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

Yes ( ) No

* delegate whole units of responsibility with the appropriate level of responsibility? ( ) Yes ( ) No

<

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

b>* select the right person for the task? ( ) Yes ( ) No

* communicate so they understand the first time? ( ) Yes

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

( ) No

* hold regular, brief, but effective meetings so that they will be informed about developments affecting thei

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

r jobs? ( ) Yes ( ) No

* take time to listen to them? ( ) Yes ( ) No

* respond to them openly, candidly, an

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

fairly? ( ) Yes ( ) No

* conduct fair and consistent job evaluations? ( ) Yes ( ) No

* support their educat

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ional pursuits? ( ) Yes ( ) No

* encourage them to join trade, professional, or civic organizations? ( ) Yes ( ) No

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

* accept and implement their suggestions? ( ) Yes ( ) No

Total your score. If your No's outnumber your Yes re

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

sponses, it's time to sit down with your employees and find out from them what you can do to enhance their motivational climat

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

.

Remember: When you maximize your potential, everyone wins. When you don't, we all lose.

© Etienne A. Gibbs, MSW<

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

/b>

PERMISSION TO REPUBLISH: This article may be republished in ezines, newsletters, and on web sites provided attribu

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

tion is provided to the author, and it appears with the included copyright, resource box and live web site link. Email notice

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

of intent to publish is appreciated but not required. E mail: eagibbs@ureach.com

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Digg It - Enhancing the Motivational Climate of Your Workplace

Related Articles: